Full-Time

Senior Scientist

Cerevel Therapeutics

Cerevel Therapeutics

201-500 employees

Develops therapies for central nervous system disorders

Biotechnology

Senior

Cambridge, MA, USA

Requirements
  • Ph.D. in relevant discipline with 2+ years relevant work experience
  • B.S. / M.S. in relevant discipline with 8+ years relevant work experience
  • Expertise in late phase and commercial analytical development
  • Experience with managing external testing laboratories
  • Subject matter proficiency in the analytical development of oral formulations
  • Knowledge of cGMPs and associated regulatory and quality compliance
Responsibilities
  • Guide and drive analytical method development
  • Provide technical support and management of outsourced drug substance and drug product method development activities
  • Manage analytical testing activities
  • Present technical data to cross functional teams and senior management
  • Design, support, and analyze method transfer and validation activities
  • Author and review drug product and drug substance analytical sections for regulatory submissions
  • Support quality investigations and resolve them in a timely manner
  • Train and recruit late-phase and commercial CMC staff
  • Identify and advocate new and emerging technologies in analytical and physical characterization analysis
  • Partner with Chemical Process Development and Formulation Development staff

Cerevel Therapeutics stands out as a leading biopharmaceutical company with a concentrated focus on developing therapies for central nervous system disorders, a field that impacts hundreds of millions globally. Their competitive edge lies in their robust portfolio of experimental neuroscience therapies, including three clinical-stage compounds and several pre-clinical compounds, targeting a wide range of disorders such as Parkinson’s, Alzheimer’s, and epilepsy. The company's culture is driven by a commitment to understanding neurocircuitry deficits, which fuels their research and development efforts towards addressing these underserved areas and communities.

Company Stage

IPO

Total Funding

$1.8B

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

7%

1 year growth

16%

2 year growth

58%